McKesson company profile
Company profile
McKesson has 41,600 employees and is headquartered in Irving, United States.
Founded in 1833 and headquartered in Irving, Texas, the group works across the healthcare chain in the United States and in several countries abroad. Its activities are organized into four segments, covering pharmacy distribution, oncology and multispecialty care, prescription technology and medical-surgical solutions. The products it handles include branded and generic medicines, specialty and biosimilar drugs, over-the-counter items and vaccines, which it delivers to retail pharmacies, hospitals, long-term care facilities, clinics and other institutions. For manufacturers it provides logistics and distribution, and it also sells consulting, outsourcing and digital tools such as electronic prior authorization and prescription price transparency. Working with benefit managers, insurers and biopharma firms, it also addresses patients' access to medication, its affordability and adherence to treatment.
In the fiscal year ended March 2026, revenue reached 403.4 billion dollars, up 12.4% from the previous year, and net income stood at 4.8 billion dollars. The company employs 41,600 people.
Company facts
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- United States
- Headquarters
- 6555 State Highway 161, 75039, Irving
- Employees
- 41,600
- Chief executive
- Brian Tyler
- Founded
- 1833
- Fiscal year
- April - March
- Listing
- MCK · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US58155Q1031
- Website
- mckesson.com
McKesson and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| McKessonMCK | United States | $126.04B | 41,600 | 1.6% | 28.2 |
| CencoraCOR | United States | $68.11B | 47,000 | 1.4% | 20.0 |
| Cardinal HealthCAH | United States | $64.97B | 58,788 | 1.3% | 36.4 |
| Henry ScheinHSIC | United States | $9.17B | 25,000 | 5.8% | 22.7 |
| Sigma HealthcareSIG | Australia | $22.55B | — | 9.2% | 48.3 |
| Sinopharm Group Ltd H1099 | Hong Kong SAR China | $6.68B | 94,910 | 3.0% | 6.51 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
